Literature DB >> 21846423

A latent class approach to the external validation of respiratory and non-respiratory panic subtypes.

R Roberson-Nay1, S J Latendresse, K S Kendler.   

Abstract

BACKGROUND: The phenotypic variance observed in panic disorder (PD) appears to be best captured by a respiratory and non-respiratory panic subtype. We compared respiratory and non-respiratory panic subtypes across a series of external validators (temporal stability, psychiatric co-morbidity, treatment response) to determine whether subtypes are best conceptualized as differing: (1) only on their symptom profiles with no other differences between them; (2) on a quantitative (i.e. severity) dimension only; or (3) qualitatively from one another.
METHOD: Data from a large epidemiological survey (National Epidemiologic Survey on Alcohol and Related Conditions) and a clinical trial (Cross-National Collaborative Panic Study) were used. All analytic comparisons were examined within a latent class framework.
RESULTS: High temporal stability of panic subtypes was observed, particularly among females. Respiratory panic was associated with greater odds of lifetime major depression and a range of anxiety disorders as well as increased treatment utilization, but no demographic differences. Treatment outcome data did not suggest that the two PD subtypes were associated with differential response to either imipramine or alprazolam.
CONCLUSIONS: These data suggest that respiratory and non-respiratory panic represent valid subtypes along the PD continuum, with the respiratory variant representing a more severe form of the disorder.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21846423      PMCID: PMC4045419          DOI: 10.1017/S0033291711001425

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  23 in total

1.  Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators.

Authors: 
Journal:  Br J Psychiatry       Date:  1992-02       Impact factor: 9.319

2.  Patterns of comorbidity in panic disorder and agoraphobia.

Authors:  V Starcevic; E H Uhlenhuth; R Kellner; D Pathak
Journal:  Psychiatry Res       Date:  1992-05       Impact factor: 3.222

3.  Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia.

Authors:  E Robins; S B Guze
Journal:  Am J Psychiatry       Date:  1970-01       Impact factor: 18.112

4.  Overview of the Cross-National Collaborative Panic Study.

Authors:  G L Klerman
Journal:  Arch Gen Psychiatry       Date:  1988-05

5.  Current and lifetime comorbidity of the DSM-IV anxiety and mood disorders in a large clinical sample.

Authors:  T A Brown; L A Campbell; C L Lehman; J R Grisham; R B Mancill
Journal:  J Abnorm Psychol       Date:  2001-11

6.  Syndrome comorbidity in patients diagnosed with a DSM-III-R anxiety disorder.

Authors:  W C Sanderson; P A DiNardo; R M Rapee; D H Barlow
Journal:  J Abnorm Psychol       Date:  1990-08

7.  Association of the functional V158M catechol-O-methyl-transferase polymorphism with panic disorder in women.

Authors:  Katharina Domschke; Christine M Freitag; Gregor Kuhlenbäumer; Anja Schirmacher; Philipp Sand; Peter Nyhuis; Christian Jacob; Jürgen Fritze; Petra Franke; Marcella Rietschel; Henk S Garritsen; Rolf Fimmers; Markus M Nöthen; Klaus-Peter Lesch; Florian Stögbauer; Jürgen Deckert
Journal:  Int J Neuropsychopharmacol       Date:  2004-03-05       Impact factor: 5.176

8.  The epidemiology of anxiety disorders: the Epidemiologic Catchment Area (ECA) experience.

Authors:  D A Regier; W E Narrow; D S Rae
Journal:  J Psychiatr Res       Date:  1990       Impact factor: 4.791

9.  Catechol O-methyltransferase genetic polymorphism in panic disorder.

Authors:  Jong-Min Woo; Kyung-Sik Yoon; Bum-Hee Yu
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

10.  Evidence for a susceptibility locus for panic disorder near the catechol-O-methyltransferase gene on chromosome 22.

Authors:  Steven P Hamilton; Susan L Slager; Gary A Heiman; Zemin Deng; Fatemeh Haghighi; Donald F Klein; Susan E Hodge; Myrna M Weissman; Abby J Fyer; James A Knowles
Journal:  Biol Psychiatry       Date:  2002-04-01       Impact factor: 13.382

View more
  4 in total

1.  Clinical Correlates of Carbon Dioxide Hypersensitivity in Children.

Authors:  Lance M Rappaport; Christina Sheerin; Dever M Carney; Kenneth E Towbin; Ellen Leibenluft; Daniel S Pine; Melissa A Brotman; Roxann Roberson-Nay; John M Hettema
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2017-09-27       Impact factor: 8.829

Review 2.  Lifelong opioidergic vulnerability through early life separation: a recent extension of the false suffocation alarm theory of panic disorder.

Authors:  Maurice Preter; Donald F Klein
Journal:  Neurosci Biobehav Rev       Date:  2014-04-13       Impact factor: 8.989

3.  The use of latent variable mixture models to identify invariant items in test construction.

Authors:  Richard Sawatzky; Lara B Russell; Tolulope T Sajobi; Lisa M Lix; Jacek Kopec; Bruno D Zumbo
Journal:  Qual Life Res       Date:  2017-08-23       Impact factor: 4.147

4.  Panic disorder respiratory subtype: psychopathology and challenge tests - an update.

Authors:  Renata T Okuro; Rafael C Freire; Walter A Zin; Laiana A Quagliato; Antonio E Nardi
Journal:  Braz J Psychiatry       Date:  2020-02-14       Impact factor: 2.697

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.